dpp 4 inhibitors and glp 1 agonists together Neuroprotection by dipeptidyl-peptidase-4 glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer's disease Use of DPP-4 inhibitors and
Description
ERJ Open Res
doi: 10.1016/J.OPHTHA.2024.08.023 81 CheungNMitchellPWongTY
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 202.Bloomer R., et al
This extended interval tests your ability to function without frequent GLP-1 support while maintaining a safety net
Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy

J Clin Invest (1987) 79(2):6169
